abagovomab 49
abciximab 43
abituzumab 35
abrilumab 26
actoxumab 30
adalimumab 21
aducanumab 20
afasevikumab 16
alacizumab_pegol 14
alemtuzumab 41
alirocumab 19
amatuximab 54
andecaliximab 33
anifrolumab 32
anrukinzumab 21
aprutumab 20
aprutumab_ixadotin 20
arcitumomab 25
ascrinvacumab 24
atezolizumab 16
atinumab 21
avelumab 18
basiliximab 53
bavituximab 47
begelomab 44
benralizumab 34
bevacizumab_beta 25
bezlotoxumab 30
bimagrumab 25
bleselumab 37
blinatumomab 51
blosozumab 42
bococizumab 31
brazikumab 24
brentuximab_vedotin 46
briakinumab 25
brodalumab 31
brolucizumab 33
brontictuzumab 37
burosumab 39
cabiralizumab 41
camrelizumab 17
canakinumab 24
cantuzumab_ravtansin 52
carlumab 28
carotuximab 21
cergutuzumab_amunaleukin2 36
cergutuzumab_amunaleukin 36
certolizumab_pegol 29
cetiximab 44
citatuzumab_bogatox 35
cixutumumab 48
clivatuzumab_tetraxetan 35
codrituzumab 26
conatumumab 26
concizumab 22
crenezumab 20
crizanlizumab 35
crotedumab 29
dacetuzumab 24
daclizumab 27
dalotuzumab 40
dapirolizumab_pegol 30
daratumumab 16
dectrekumab 15
demcizumab 41
denosumab 8
depatuxizumab 35
depatuxizumab_mafodotin 35
dezamizumab 36
dinutuximab 45
diridavumab 35
domagrozumab 18
drozitumab 21
duligotuzumab 22
durvalumab 17
dusigitumab 39
efalizumab 40
efungumab 28
eldelumab 20
elezanumab 38
elgemtumab 14
elotuzumab 22
emactuzumab 36
emapalumab 29
emibetuzumab 34
enavatuzumab 29
enfortumab_vedotin 18
enoblituzumab 24
enokizumab 36
enoticumab 27
ensituximab 42
eptinezumab 20
erenumab 32
etaracizumab 17
etrolizumab 25
evinacumab 25
evolocumab 36
farletuzumab 8
fasinumab 34
fezakinumab 38
fibatuzumab 31
ficlatuzumab 37
firivumab 36
flanvotumab 28
fletikumab 44
foralumab 19
foravirumab 21
fremanezumab 32
fresolimumab 26
fulranumab 26
futuximab 37
galcanezumab 26
ganitumab 32
gantenerumab 16
gemetuzumab 37
gemtuzumab2 39
gemtuzumab 35
gevokizumab 35
girentuximab 35
glembatumumab 35
glembatumumab_vedotin 35
guselkumab 35
ibalizumab 37
ibritumomab 48
icrucumab 16
idarucizumab 43
ifabotuzumab 31
imalumab 15
imgatuzumab 37
inclacumab 26
indatuximab_ravtansin 41
indusatumab 31
inebilizumab 33
intetumumab 20
iodine_girentuximab 33
ipilimumab 5
iratumumab 27
isatuximab 45
itolizumab 33
ixekizumab 36
labetuzumab_govitecan 29
lambrolizumab 42
lampalizumab 30
lanadelumab 23
landogrozumab 22
laprituximab 39
lebrikizumab 40
lendalizumab 39
lenzilumab 33
lifastuzumab_vedotin 26
ligelizumab 35
lilotomab 41
lirilumab 38
lodelcizumab 32
lokivetmab 25
lorvotuzumab_mertansin 24
lucatumumab 33
lumretuzumab 31
lupartumab 21
lutikizumab 19
margetuximab 42
milatuzumab 36
mirvetuximab 50
mirvetuximab_soravtansin 50
modotuximab 58
mogamulizumab 24
monalizumab 37
motavizumab 38
moxetumomab_pasudotox 26
namilumab 39
naratuximab 49
naratuximab_emtansin 49
narnatumab 22
navicixizumab2 31
navicixizumab 42
navivumab 47
necitumumab 28
nemolizumab 41
nesvacumab 14
nivolumab 21
obiltoxaximab 28
obinutuzumab 38
ocaratuzumab 35
ofatumumab 20
olaratumab 39
olokizumab 29
omalizumab 25
onartuzumab 26
ontuxizumab 34
opicinumab 16
orticumab 16
otelixizumab 40
oxelumab 14
ozanezumab 32
pamrevlumab 17
panobacumab 20
parsatuzumab 34
pasotuxizumab 19
pateclizumab 23
patritumab 34
pembrolizumab 42
perakizumab 26
pidilizumab 21
pinatuzumab_vedotin 21
plozalizumab 28
pogalizumab 38
polatuzumab_vedotin 25
ponezumab 46
prezalumab 19
pritoxaximab 51
quilizumab 20
racotumomab 43
radretumab 19
ralpancizumab 35
ramucirumab 21
ranevetmab 33
ranibizumab 24
refanezumab 28
remtolumab 22
rilotumumab 32
rinucumab 28
risankizumab 39
rituximab 37
rivabazumab 27
robatumumab 22
roledumab 32
romosozumab 38
rontalizumab 29
rosmantuzumab 36
rozanolixizumab 24
sacituzumab 34
sacituzumab_govitecan 34
samalizumab 41
sapelizumab 38
sarilumab 23
secukinumab 24
seribantumab 21
setoxaximab 46
sifalimumab 23
siltuximab 29
simtuzumab 40
sirukumab 16
solanezumab 29
solitomab 34
stamulumab 35
suptavumab 31
suvizumab 22
tabalumab 34
tadocizumab 29
tamtuvetmab 35
tanezumab 34
tarextumab 14
tavolixizumab 30
telisotuzumab 43
teplizumab 25
tesidolumab 36
tezepelumab 30
tigatuzumab 16
tildrakizumab 35
timolumab 20
tisotumab 16
tosatoxumab 43
tositumomab 45
tralokinumab 44
trastuzumab 28
tregalizumab 25
trevogrumab 17
ublituximab 41
urelumab 33
ustekinumab 37
utomilumab 36
vadastuximab 42
vadastuximab_talirin 42
vandortuzumab_vedotin 24
vantictumab 29
vanucizumab2 25
vanucizumab 53
varlilumab 22
vatelizumab 39
vedolizumab 38
veltuzumab 29
vesencumab 15
vorsetuzumab 38
vorsetuzumab_mafodotin 38
vunakizumab 42
xentuzumab 24
zatuximab 58
